Milrinone Versus Dobutamine in Critically Ill Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT03207165

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03207165
Other papers using this trial's data
  • Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial Critical care (London, England), 2021-08-10 DOI, PubMed 34376218, PMC8356445 In the PMC Open Access subset under CC BY.
  • Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock Journal of the American Heart Association, 2021-11-02 DOI, PubMed 34713704, PMC8751815 In the PMC Open Access subset under CC BY-NC-ND.
  • Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial Journal of the American Heart Association, 2022-03-15 DOI, PubMed 35261289, PMC9075306 In the PMC Open Access subset under CC BY-NC-ND.
  • Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock The New England journal of medicine, 2021-08-05 DOI, PubMed 34347952

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03207165. Randomized; quadruple masking; primary purpose treatment. Start 2017-08-30 (actual); primary completion 2020-06-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Milrinone Versus Dobutamine in Critically Ill Patients
Condition
Low Cardiac Output Syndrome
Condition
Cardiogenic Shock
Condition
Acute Coronary Syndrome
Condition
Pulmonary Edema
Intervention (Drug)
Milrinone
Intervention (Drug)
Dobutamine
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct03207165
Content hash
39cfb2890144146f40be72c6776801befc5ac2caa80cc478290d93a950ef5fd3